Sanofi (France) Hid MS Drug's Checkered History, Investors Say

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Law360, New York (April 04, 2014, 8:36 PM ET) -- Sanofi SA and its top executives allegedly misled investors about the potential success of its subsidiary's multiple sclerosis drug Lemtrada, causing shareholders to miss out on millions of dollars when the drug failed to receive regulatory approval, a complaint filed in New York federal court claims.

Help employers find you! Check out all the jobs and post your resume.

Back to news